Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 2 Eli Lilly FDA Plays With Great Potential And Limited Downside
2 Eli Lilly FDA Plays With Great Potential And Limited Downside
2 Eli Lilly FDA Plays With Great Potential And Limited Downside
Submitted by
admin
on February 29, 2012 - 4:49pm
Source:
Seeking Alpha
News Tags:
Eli Lilly
FDA
solanezumab
Alzheimer's disease
Headline:
2 Eli Lilly FDA Plays With Great Potential And Limited Downside
Do Not Allow Advertisers to Use My Personal information